Helen Tomkinson
Impact in
- Modeling and Simulation top 10%
- Mathematical Biology Tumor Growth
-
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 14
- Colorectal Cancer Treatments and Studies 4
- PARP inhibition in cancer therapy 4
-
- PI3K/AKT/mTOR signaling in cancer 6
- Melanoma and MAPK Pathways 3
- Co-authors
- Nidal Al‐Huniti (8 shared papers)Eric Masson (6 shared papers)Gabriel Helmlinger (4 shared papers)Lulu Chu (2 shared papers)Kirill Peskov (2 shared papers)Karthick Vishwanathan (7 shared papers)Veronika Voronova (1 shared paper)Donald R. Stanski (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (5 papers)The Journal of Clinical Pharmacology (4 papers)Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)Clinical Pharmacology & Therapeutics (3 papers)
- Partner nations
- United KingdomUnited StatesPoland
In The Last Decade
Helen Tomkinson
38 papers receiving 454 citations
Peers
Comparison fields: 5 of 72
- Modeling and Simulation 30
- Oncology 150
- Genetics 59
- Hematology 50
- Pharmacology 29
Countries citing papers authored by Helen Tomkinson
This map shows the geographic impact of Helen Tomkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Tomkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Tomkinson more than expected).
Fields of papers citing papers by Helen Tomkinson
This network shows the impact of papers produced by Helen Tomkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Tomkinson. The network helps show where Helen Tomkinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Tomkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 85 | |
| 2 | 2017 | 39 | |
| 3 | 2011 | 29 | |
| 4 | 2018 | 26 | |
| 5 | 2017 | 25 | |
| 6 | 2018 | 17 | |
| 7 | 2017 | 16 | |
| 8 | 2017 | 15 | |
| 9 | 2019 | 15 | |
| 10 | 2022 | 14 | |
| 11 | 2021 | 14 | |
| 12 | 2017 | 14 | |
| 13 | 2021 | 13 | |
| 14 | 2018 | 13 | |
| 15 | 2017 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2011 | 11 | |
| 18 | 2021 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2021 | 9 |
About Helen Tomkinson
Helen Tomkinson is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Hematology, having authored 40 papers that have together received 466 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Chronic Lymphocytic Leukemia Research (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (4 papers), PARP inhibition in cancer therapy (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Modeling and Simulation (30 citations), Oncology (150 citations), Genetics (59 citations), Hematology (50 citations) and Pharmacology (29 citations). Helen Tomkinson has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include Nidal Al‐Huniti, Eric Masson, Gabriel Helmlinger, Lulu Chu, Kirill Peskov, Karthick Vishwanathan, Veronika Voronova, Donald R. Stanski, Simon J. Dovedi and Yuri Kosinsky. Their work appears in journals such as British Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, Journal of Clinical Oncology, Cancer Research and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.